mFOLFIRINOX And STEreotactic body Radiotherapy (SBRT) for Pancreatic cancer with high-risk and Locally AdvaNced disease (MASTERPLAN)...(MRFF LSCD administered by The University of Sydney) (2019–2024)

Grant type:
University of Sydney
Researchers:
  • Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
    Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
    Affiliate Professor of Frazer Insti
    Frazer Institute
    Faculty of Medicine
Funded by:
The University of Sydney